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Abstract: Study Design: A prospective, non-comparative study of 27 patients to evaluate the safety and performance of 
the Memory Metal Spinal System used in a PLIF procedure in the treatment of spondylolisthesis, symptomatic spinal 
stenosis or degenerative disc disease (DDD). 
Objective: To evaluate the clinical performance, radiological outcome and safety of the Memory Metal Spinal System, 
used in a PLIF procedure, in the treatment of spondylolisthesis, symptomatic spinal stenosis or degenerative disc disease 
in human subjects. 
Summary of Background Data: Spinal systems that are currently available for correction of spinal deformities or 
degeneration such as lumbar spondylosis or degenerative disc disease, use components manufactured from stainless steel 
or titanium and typically comprise two spinal rods with associated connection devices. The Memory Metal Spinal System 
consists of a single square spinal rod made from a nickel titanium alloy (Nitinol) used in conjunction with connection 
devices. Nitinol is characterized by its shape memory effect and is a more flexible material than either stainless steel or 
titanium. With current systems there is loss of achieved reposition due to the elastic properties of the spine. By using a 
memory metal in this new system the expectation was that this loss of reposition would be overcome due to the metal’s 
inherent shape memory properties. Furthermore, we expect a higher fusion rate because of the elastic properties of the 
memory metal. 
Methods: Twenty-seven subjects with primary diagnosis of spondylolisthesis, symptomatic spinal stenosis or degenerative 
disc disease (DDD) were treated with the Memory Metal Spinal System in conjunction with the Brantigan IF® Cage in 
two consecutive years. Clinical performance of the device was evaluated over 2 years using the Oswestry Disability Index 
(ODI), Short Form 36 questionnaire (SF-36) and pain visual analogue scale (VAS) scores. Safety was studied by 
collection of adverse events intra-operative and during the followup. Interbody fusion status was assessed using 
radiographs and a CT scan. 
Results: The mean pre-operative ODI score of 40.9 (±14.52) significantly improved to 17.7 (±16.76) at 24 months post-
operative. Significant improvement in the physical component from the SF36 questionnaire was observed with increases 
from the baseline result of 42.4 to 72.7 at 24 months (p<.0001); The emotional component in the SF36 questionnaires 
mean scores highlighted a borderline significant increase from 56.5 to 81.7 at 24 months (p=0.0441). The average level of 
leg pain was reduced by more than 50% postoperation (VAS values reduced from 5.7 (±2.45) to 2.2 (±2.76) at 24 month 
post-operation with similar results observed for back pain. CT indicated interbody fusion rate was not significantly faster 
compared to other devices in literature. No device related adverse events were recorded in this study. 
Conclusions: The Memory Metal Spinal System, different from other devices on the market with regard to material and 
the one rod configuration, is safe and performed very well by improving clinically important outcomes in the treatment of 
spondylolisthesis, symptomatic spinal stenosis or degenerative disc disease. In addition the data compares favorably to 
that previously reported for other devices in the literature. 
Keywords: Memory metal spinal system, PLIF, spondylolisthesis, degenerative disc disease, spinal fusion. 
INTRODUCTION 
  Chronic low back pain can be the result of 
spondylolisthetic or degenerative lumbar segmental 
instability [1, 2]. Surgical treatment of this condition by   
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fusion of the involved segments was introduced in the mid-
1920s [1, 3]. Treatment of this condition is one of the most 
resources demanding in the Western world [4-7]. Indications 
of this operative technique, and outcome of this surgery are 
intensely debated [8-15]. The idea of lumbar or lumbosacral 
arthrodesis is to eliminate motion and thus to relieve pain 
[16]. King in 1944 [17] introduced internal spinal fixation in 
the lumbosacral region. The use of the pedicle for screw The Memory Metal Spinal System in a PLIF Procedure  The Open Orthopaedics Journal, 2012, Volume 6    221 
placement was introduced in 1969 [18], and efficient screw-
rod connections have also been developed [19, 20]. 
  Our goal was to develop a less rigid fixation device to 
enhance intervertebral fusion [21]. 
  The Memory Metal Spinal System is a posterior system, 
consisting of Titanium pedicle screws and bridges and a 
single square memory metal rod. Spinal systems that are 
currently available use components manufactured from 
stainless steel or titanium. The spinal rod component used in 
this system is manufactured from Nitinol (NiTi), a nickel-
titanium alloy. The characteristics of this alloy were first 
described by Buehler and Wang [22]. At present, the 
characteristics of this NiTi alloy are used clinically in wires 
for orthodontic tooth alignment, osteosynthesis staples, vena 
cava filters and other vascular applications [23-28]. The 
biocompatibility and safety of memory metal are discussed 
in literature [29, 30]. 
  NiTi is a Memory Metal and is mainly characterized by 
its shape memory effect and its superelasticity. By using a 
memory metal in this new system the expectation was that 
there is a better maintenance of the reposition due to the 
metal’s inherent shape memory properties (continues 
reposition force) and enhancement of the fusion due to a less 
rigid system. Although correction in deformity (reposition) 
was not specifically tested in the current study, shape 
memory is an important property of memory metal and its 
potential in spinal correction has yet to be fully explored. 
  In this study the Memory Metal Spinal System was 
implanted in humans for the first time and used in 
conjunction with Brantigan IF® carbon fibre reinforced 
polymer fusion cage. Brantigan IF® cages have been used in 
the clinical setting for ten years with excellent outcomes 
reported at both 2 years [31,32] and 10 years post-surgery 
[33]. 
  The main objectives of this study were to evaluate the 
fusion, the clinical performance, and safety of the Memory 
Metal Spinal System, used in a PLIF procedure, in the 
treatment of spondylolisthesis, symptomatic spinal stenosis 
or degenerative disc disease in humans. 
MATERIALS AND METHODS 
  This was a multi-centre, prospective, non-comparative, 
post marketing surveillance (PMS) study to evaluate the 
Memory Metal Spinal System, used in conjunction with the 
Brantigan IF® Cage, in subjects who underwent a PLIF 
procedure. 
Patients 
  Twenty-seven consecutive patients (9 male and 18 
female) with a diagnosis of a symptomatic single level 
degenerative lumbar disc consented were treated with the 
Memory Metal Spinal System, used in conjunction with the 
Brantigan IF® Cage, following Research Ethics Committee 
approval. Inclusion criteria required all patients aged 18 
years and over, with disabling back and/or refractory 
radicular pain who have had at least six weeks of 
conservative management, with moderate to severe 
degenerative changes in one or two lumbar disc levels based 
on MRI performed not more than three months prior to study 
entry. In addition discography had been provocative for 
patients back pain. Exclusion criteria ruled out patients with 
more than two abnormal lumbar disc levels, evidence of 
infection in the disc or spine, spinal tumor(s), who are 
immunocompromized, pregnant, and/or have a condition 
which would compromised their participation and follow-up 
in this study. Conservative treatment mostly entailed a 
combination of appropriate analgesics, physical therapy, and 
epidural and/or facet injections. 
Implant Features 
  The Memory Metal Spinal System consists of pedicle 
screws, bridge connectors and one single square rode, made 
of a nickel-titanium alloy (Fig. 1). All the spinal rods used in 
the study were manufactured from medical grade nickel 
titanium alloy (also referred to as Nitinol or Shape Memory 
Alloy) according to ASTM F2063-00 standard. The rods 
have a 6.35mm square cross-section, similar to current 
systems and are available straight or pre-bent (pre-lordosed). 
The length of the rods can be cut to the specific length 
required by the surgeon by using a specially designed cutter. 
Standard pedicle screws were used (Monarch TMpedicle 
screw system, DePuy International). The transverse 
connector bridge is a device, which is fixed between two 
pedicle screws to produce a stable, rigid construct. The 
flexibility of the system comes from the rod. The rod is 
connected to the bridge and locked in place by a setscrew 
and sliding cap. The rod can be approximated to the bridge 
using a mini approximator instrument. All connection 
bridges are manufactured from medical grade Titanium 
Alloy that is considered safe to use with Nitinol. 
 
Fig. (1). The single rod Memory Metal Spinal System. 
  Two experienced spine surgeons performed all surgeries 
in two consecutive years. A standard PLIF procedure was 
performed using the Memory Metal Spinal System (DePuy 
International) where after the Brantigan IF® Cage (DePuy 
International) was filled with autologous bone and placed in 
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Clinical and Radiological Outcome 
  Patients were evaluated pre-operatively at 1, 3, 6, 12 and 
24 month after surgery. Evaluation at each interval included 
physical and neurological examination, concomitant 
medication, additional surgical procedures, subject 
completed questionnaires (Oswestry Disability Index, Short 
Form-36 Health) and Visual Analogue Scale for Pain. Any 
adverse events and complications were recorded. 
  Routine lateral and AP radiographs were obtained at each 
interval. Routine radiographs were used to evaluate the total 
intervertebral height and subsidence. The CT scan at two 
years follow-up was used to determine fusion. Interbody 
fusion was defined as complete bridging at any one or more 
points within the central area of the vertebral body as 
determined by CT. One independent radiologist who was not 
otherwise involved in the study determined intervertebral 
fusion assessments. Fusion was recorded as Yes/No/Can’t 
Assess. 
  Complications were divided into intra-operative and 
post-operative adverse events. 
Statistics 
  For statistical analysis, comparisons between pre- and 
postoperative scores were made using paired t-tests. 
RESULTS 
Clinical Data 
  All 27 patients completed the 24 months of follow-up 
without any major adverse event. The average age of the 
patients was 44.3 (range 23.1-73.9). All patients had 
symptomatic single level degenerative lumbar disc (one 
patient L3-4, ten patients L4-5 and sixteen patients L5-S1). 
  The Oswestry Disability Index (ODI) functional outcome 
data compared baseline and post-operative results. The ODI 
mean score pre-operative was 40.9 (±14.52). This 
significantly improved to 17.7 (±16.76) at 24 months post-
operative (p<.0001). 
  Significant improvement in the physical component from 
the SF36 questionnaire was observed with increases from the 
baseline result of 42.4 to 72.7 (±21.74) at 24 months 
(p<.0001); the emotional component in the SF36 
questionnaires mean scores highlighted a borderline 
significant increase from 56.5 to 81.7 (±29.57) at 24 months 
(p=0.0441). 
  The average level of leg pain was reduced by more than 
50% post-operation (VAS values reduced from 5.7 (±2.45) 
to 2.1 (±2.30) at 1 month post-operation). This reduction 
remained constant over the 24 months post-operation (2.2 
(±2.76) at 24 month post-operation). A similar reduction in 
back pain was also revealed. 
  Bivariate analysis indicated that gender; previous non-
surgical treatment, smoking history, and obesity had no 
statistical effect on clinical or fusion success. 
Radiological Assessment 
  X-rays were performed on standing patients with both 
AP and lateral views being taken. The pre-operative and 
post-operative radiographic assessments were carried out on 
the patient population. A CT scan and X-rays were 
performed at 24 months post-operative. The data is 
illustrated in Fig. (2). An example of solid fusion on X-ray 
and CT is illustrated in Fig. (3a, b). 
Safety 
  During the 27 surgical implanting procedures, four intra-
operative complications occurred. There was 1 (3.7%) 
malpositioning of a pedicle screw, 1 (3.7%) breakage of a 
cage and there were 2 (7.4%) dural tears. The implant 
breakage involved the inserted interbody fusion cage. The 
fracture was located around the threaded hole for the 
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insertion tool and occurred on impaction into the disc space. 
The 2 dural tears were repaired during surgery, there was no 
neurologic injury and the hospital course was not affected. 
None of the adverse events were related to the device under 
investigation (i.e. biocompatibility issues). 
 
Fig. (3a). “Solid fusion” status (X-Ray). 
 
Fig. (3b). “Solid fusion” status (CT). 
DISCUSSION 
  Twenty-seven subjects with primary diagnosis of 
spondylolisthesis, symptomatic spinal stenosis or 
degenerative disc disease (DDD) were treated with the 
Memory Metal Spinal System in conjunction with the 
Brantigan IF® Cage. The mean pre-operative ODI score of 
40.9 (±14.52) significantly improved to 17.7 (±16.76) at 24 
months post-operative. Significant improvement in the 
physical component from the SF36 questionnaire was 
observed with increases from the baseline result of 42.4 to 
72.7 at 24 months (p<.0001); The emotional component in 
the SF36 questionnaires mean scores highlighted a 
borderline significant increase from 56.5 to 81.7 at 24 
months (p=0.0441). The average level of leg pain was 
reduced by more than 50% post-operation (VAS values 
reduced from 5.7 (±2.45) to 2.2 (±2.76) at 24 month post-
operation with similar results observed for back pain. 
  The clinical outcome in this study is comparable to the 
literature. A study of 60 patients with posterior lumbar 
interbody fusion combined with instrumented postero-lateral 
fusion reported by Freeman et al. [36] indicated stable 
circumferential fixation as shown by radiographs and 
tomograms confirming the presence of a bridging fusion 
mass. Of the 48 ODI questionnaires completed after 5 years, 
79% had an ODI <30. In the present study 74% (17/23) of 
the patients indicated an ODI < 30. McKenna et al. reported 
a prospective, randomized controlled trial of femoral ring 
allograft (FRA) versus a titanium cage (TC) in 
circumferential lumbar spinal fusion with minimum 2 years 
clinical results [37]. Comparison of change in ODI results 
indicated a significantly greater improvement in the FRA 
group (reduced from 57 to 42) when compared to the TC 
group (54 reduced to 48). The corresponding change in ODI 
results from baseline over 2 years in the current Memory 
Metal Spinal System study was greater than that of either the 
FRA or TC groups (23 versus 15 and 6). Both FRA and TC 
patients showed a significant improvement in VAS for back 
pain (change in VAS 1.9 and 1.1 respectively). However 
with leg pain VAS scores only FRA patients demonstrated a 
significant improvement (change in VAS of 1.3) whereas the 
TC group had more leg pain increasing the VAS scores 
postoperatively by 0.4 points. VAS results from the Memory 
Metal Spinal System study for both back and leg pain show a 
much greater improvement when compared to both groups in 
the FRA / TC study. Part of the explanation is that our 
patient group had significant more grade spondylolisthesis 
and therefore more leg pain. The review of Boos & Webb 
[38] suggests that PLIF in these cases do better than fusion 
alone. A study with two different patient groups of 30 
subjects having spondylolisthesis, which were subjected to 
different surgeries: posterior lumbar fusion with pedicle 
screws (Group I) and posterior lumbar interbody fusion with 
pedicle screws (Group II) has also been reported [39]. The 
ODI mean scores pre-operatively and 2 years post-
operatively were 28.5 and 18.6 respectively for Group I and 
31.3 and 13.3 respectively for Group II. The ODI scores in 
the current study show a comparable result. Glassman et al. 
reviewed the ODI and SF36 outcomes in a multicentre 
lumbar fusion study with follow up after 2 years [40]. The 
minimal clinically important difference (MCID) seeks to 
differentiate a magnitude of change, which is not only 
statistically valid but also of real clinical value. Figures for 
MCID for ODI results have been reported as low as a 4 
points decrease [41] and also a 10 points decrease [42]. The 
Food and Drug Administration (FDA) standards suggest a 15 
point decrease in ODI and either maintenance of or any 
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[43]. Ware et al. [44] reported that an increase of 5.42 points 
in the SF-36 PCS is clinically important. A more recent 
study [45] has reported the following MCID values: 12.8 
points for ODI, 4.9 points for SF-36 PCS, 1.2 points for back 
pain and 1.6 points for leg pain. The improvement in ODI 
values for the various fusion treatments in the multicentre 
review ranged from 9.9 to 22.2 points whereas the 
improvement in SF-36 data ranged from 13.8 to 6.3 points. 
The improvement in the corresponding ODI and SF-36 
values in the current Memory Metal Spinal System study 
were 23 and 31. The improvement in back and leg pain were 
2.5 and 3.5 respectively. The results obtained for the 
Memory Metal Spinal System have therefore satisfied the 
MCID reported in the literature. 
  Radiological assessment indicated that interbody fusion 
rate was good after two years compared to other more 
traditional devices in literature. At 24 months post-operative 
there was a big difference in fusion status between X-Ray 
(91.0%) and CT (66.7%). These results are comparable to 
literature [34]. Most studies only use plain X-ray for fusion 
assessment that gives high false positive results. Shah et al. 
[35] showed that CT provides a more sensitive assessment of 
interbody fusion than plain radiographs, with a more robust 
inter-observer agreement comparable to our study results. 
The memory metal system in this study prove to be safe in 
comparison to the reports of West et al. [46] and Pihajamski 
[47] for pedicle srew studies, Hall et al. [48] for degenerative 
disc disease treated with the Isola pedicle screw system and 
Brantigan et al. [32] for PLIF procedure. 
CONCLUSION 
  The Memory Metal Spinal System, different from other 
devices on the market with regard to material and the one-
rod configuration, is safe and performed well (in regard to 
fusion) in the treatment of spondylolisthesis, symptomatic 
spinal stenosis or degenerative disc disease. The clinical 
outcome is comparable to traditional devices in the literature. 
The results of this study were used to support the further 
development of the 3-dimensional treatment system of 
scoliotic deformities. 
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